Get the Stockscreener App
24.52
0.86%
0.21
Progyny Inc stock is traded at $24.52, with a volume of 1.34M.
It is up +0.86% in the last 24 hours and down -5.73% over the past month.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
See More
Previous Close:
$24.31
Open:
$24.29
24h Volume:
1.34M
Relative Volume:
0.83
Market Cap:
$2.11B
Revenue:
$1.13B
Net Income/Loss:
$62.75M
P/E Ratio:
38.92
EPS:
0.63
Net Cash Flow:
$170.92M
1W Performance:
-9.15%
1M Performance:
-5.73%
6M Performance:
+6.52%
1Y Performance:
+18.91%
1-Day Range:
$24.10
$24.92
1-Week Range:
$24.10
$28.75
52-Week Range:
$17.98
$28.75
Progyny Inc Stock (PGNY) Company Profile
Name
Progyny Inc
Sector
Industry
Phone
212-888-3124
Address
1359 BROADWAY, NEW YORK, NY
Compare PGNY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PGNY
Progyny Inc
|
24.52 | 2.10B | 1.13B | 62.75M | 170.92M | 0.63 |
|
UNH
Unitedhealth Group Inc
|
331.02 | 307.04B | 435.16B | 18.37B | 17.37B | 19.16 |
|
CVS
Cvs Health Corp
|
78.60 | 103.28B | 393.94B | 428.00M | 6.29B | 0.3826 |
|
ELV
Elevance Health Inc
|
374.87 | 84.88B | 194.82B | 5.53B | 3.77B | 24.45 |
|
CI
Cigna Group
|
272.21 | 74.24B | 268.22B | 6.55B | 7.44B | 22.67 |
|
HUM
Humana Inc
|
273.28 | 34.15B | 126.36B | 1.30B | 1.55B | 10.67 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-26 | Upgrade | Truist | Hold → Buy |
| Dec-09-25 | Initiated | Barclays | Overweight |
| Nov-12-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jul-08-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Dec-02-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-13-24 | Downgrade | Truist | Buy → Hold |
| Sep-19-24 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Aug-07-24 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-07-24 | Downgrade | Canaccord Genuity | Buy → Hold |
| Aug-07-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jul-16-24 | Initiated | JMP Securities | Mkt Outperform |
| May-10-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Sep-27-23 | Initiated | Canaccord Genuity | Buy |
| May-22-23 | Initiated | BTIG Research | Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-05-23 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-07-22 | Initiated | Truist | Buy |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Nov-22-21 | Downgrade | Citigroup | Buy → Neutral |
| Sep-30-21 | Initiated | Berenberg | Buy |
| Aug-12-21 | Initiated | Barclays | Overweight |
| Jun-02-21 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Mar-10-21 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-01-20 | Initiated | SVB Leerink | Outperform |
| Jun-02-20 | Initiated | Guggenheim | Buy |
| Nov-19-19 | Initiated | Citigroup | Buy |
| Nov-19-19 | Initiated | Goldman | Buy |
| Nov-19-19 | Initiated | JP Morgan | Overweight |
| Nov-19-19 | Initiated | Piper Jaffray | Overweight |
| Nov-19-19 | Initiated | SVB Leerink | Outperform |
View All
Progyny Inc Stock (PGNY) Latest News
Can Progyny’s (PGNY) Modest Guidance Raise Redefine Its Demand Resilience Narrative? - Yahoo Finance UK
Pullback Watch: Why is Progyny Inc stock going downJuly 2025 Levels & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
Aug Setups: Is Progyny Inc impacted by rising rates2025 Bull vs Bear & Expert Curated Trade Setups - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX), Regeneron (REGN) and Progyny (PGNY) - The Globe and Mail
Progyny (NASDAQ:PGNY) Reaches New 1-Year HighTime to Buy? - MarketBeat
Progyny Stock (-11%) : JPM Conference Growth Narrative Fails to Impress - Trefis
Progyny (NASDAQ:PGNY) Shares Down 5.9%Time to Sell? - MarketBeat
Progyny, Inc.'s (NASDAQ:PGNY) Stock Is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue? - 富途牛牛
Progyny stock to exceed guidance as BofA reiterates Buy rating By Investing.com - Investing.com Canada
Progyny stock to exceed guidance as BofA reiterates Buy rating - Investing.com
Zacks Industry Outlook Highlights Medpace, Enhabit and Progyny - Yahoo Finance
Progyny to discuss updated financial expectations at upcoming JP Morgan healthcare conference - marketscreener.com
Progyny To Discuss Updated Financial Expectations At Upcoming JP Morgan Healthcare Conference - TradingView — Track All Markets
Progyny Inc anticipates Q4 and full year results to be slightly above previously provided financial guidance - marketscreener.com
Progyny to Discuss Updated Financial Expectations at Upcoming JP Morgan Healthcare Conference - The Manila Times
Progyny, Inc.'s (NASDAQ:PGNY) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue? - Yahoo Finance
Progyny (PGNY) Tops Q1 Earnings and Revenue Estimates - sharewise.com
How sustainable is Progyny Inc. stock dividend payout2025 Trading Recap & Fast Moving Stock Watchlists - ulpravda.ru
Why Progyny Inc. stock remains a top recommendationRisk Management & Low Risk Growth Stock Ideas - Улправда
Progyny, Inc. (PGNY) Soars to 52-Week High, Time to Cash Out? - sharewise.com
Progyny stock hits 52-week high at 27.84 USD By Investing.com - Investing.com Nigeria
Why Progyny Inc. stock is seen as undervaluedGap Up & Low Drawdown Investment Ideas - Улправда
Progyny (NASDAQ:PGNY) stock performs better than its underlying earnings growth over last year - Sahm
PGNY: Keybanc Maintains Overweight Rating and Raises Price Targe - GuruFocus
Progyny (PGNY) Stock Hits New High: Keybanc Raises Target to $32News and Statistics - IndexBox
Rockford Register Star: Local News, Politics & Sports in Rockford, IL - FinancialContent
Progyny (PGNY) Stock Is Up, What You Need To Know - Finviz
Truist Securities upgrades Progyny stock rating to Buy on improved outlook By Investing.com - Investing.com South Africa
Truist Securities upgrades Progyny stock rating to Buy on improved outlook - Investing.com Nigeria
Progyny (NASDAQ:PGNY) Hits New 1-Year High After Analyst Upgrade - MarketBeat
Progyny (NASDAQ:PGNY) Stock Rating Upgraded by Truist Financial - MarketBeat
Progyny stock hits 52-week high at 27.84 USD - Investing.com India
How Progyny Inc. stock trades during market volatilityLayoff News & Safe Entry Point Identification - Улправда
Why Progyny’s Stock Is Quietly Breaking Higher - TipRanks
KeyBanc Maintains Progyny(PGNY.US) With Buy Rating, Raises Target Price to $32 - 富途牛牛
Progyny president’s employment to end December 2025 - MSN
Progyny jumps after CEO Anevski buys $1.93M of common stock - MSN
Liquidity Mapping Around (PGNY) Price Events - Stock Traders Daily
Progyny, Inc. (PGNY) Stock Analysis: Investor Outlook With A Promising 10% Upside - DirectorsTalk Interviews
The Truth About Progyny Inc: Is This Fertility Stock the Next Silent Millionaire Maker? - AD HOC NEWS
Progyny (NASDAQ:PGNY) Rating Increased to Strong-Buy at Zacks Research - MarketBeat
Progyny (NASDAQ:PGNY) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Progyny Earnings Notes - Trefis
2 Reasons PGNY is Risky and 1 Stock to Buy Instead - Yahoo Finance
Fort Washington Investment Advisors Inc. OH Has $35.65 Million Stake in Progyny, Inc. $PGNY - MarketBeat
Progyny rises on guidance update - MSN
Pacer Advisors Inc. Has $8.29 Million Stock Holdings in Progyny, Inc. $PGNY - MarketBeat
PGNY (Progyny) Retained Earnings : $190 Mil (As of Sep. 2025) - GuruFocus
PGNY (Progyny) Total Stockholders Equity : $560 Mil (As of Sep. 2025) - GuruFocus
PGNY (Progyny) 3-Year EPS without NRI Growth Rate : 35.40% (As of Sep. 2025) - GuruFocus
Price-Driven Insight from (PGNY) for Rule-Based Strategy - Stock Traders Daily
Progyny Inc Stock (PGNY) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.00%
4.99%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):